Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: Vela Diagnostics' Sentosa KRAS Test

Premium

Vela Diagnostics said this week that its Sentosa SA KRAS PCR Test is now available as a CE-IVD product.

The new test qualitatively assesses mutation status in DNA extracted from colorectal formalin-fixed paraffin-embedded tissues. It detects and differentiates seven mutations (G12A, G12C, G12D, G13D, G12R, G12S and G12V) in codons 12 and 13, which covers more than 97 percent of the known mutations in the KRAS gene.

The company's Sentosa SX101 nucleic acid extraction platform automates FFPE sample extraction and PCR setup for the assay, which runs on Qiagen's Rotor-Gene Q MDx system and includes positive and negative controls in the same run. Each test requires a 5-µm FFPE section with more than 10 percent tumor content.

The new test adds to Vela's oncology testing portfolio, which includes the Sentosa SA BRAF PCR Test and Sentosa SA NRAS PCR Test. The Sentosa SA KRAS PCR Test is not available for diagnostic use in the US.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.